Home Mallinckrodt Launches Additional Dosage Strengths Of Generic CONCERTA In U.S
 

Keywords :   


Mallinckrodt Launches Additional Dosage Strengths Of Generic CONCERTA In U.S

2013-03-25 09:30:00| drugdiscoveryonline News Articles

Mallinckrodt, the Pharmaceuticals business of Covidien, recently announced that it launched the 36 and 54 milligram (mg) dosage strengths of Methylphenidate HCl Extended-Release (ER) Tablets USP (CII), generic version of CONCERTA

Tags: us additional generic strengths

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
17.05House Republicans release farm bill draft
17.05House Republicans release farm bill draft
17.05Union forming stalled in US Mercedes-Benz
17.05Johnson & Johnson Acquires Atopic Dermatitis Treatment Biotech Company
More »